ID   UT62a
AC   CVCL_VK02
DR   Cosmic; 2653725
DR   Wikidata; Q98134392
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 19
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 13,14.2
ST   D21S11: 28.2,30
ST   D2S1338: 22,23
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D6S1043: 12,21
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta E: 17,19
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=28256713; DOI=10.1002/ijc.30674;
RA   Feng, Hai-Liang
RA   Zhang, Yu
RA   Liu, Kan
RA   Zhu, Yan
RA   Yang, Zhen-Li
RA   Zhang, Xu
RA   Liu, Yu-Qin
RT   "Intrinsic gene changes determine the successful establishment of
RT   stable renal cancer cell lines from tumor tissue.";
RL   Int. J. Cancer 140:2526-2534(2017).
//